Nanosomal-Mediated Lipid Suspension Delivery of Docetaxel as a Promising Landscape to Enhance the Therapeutic Potential in Triple-Negative Breast Cancer.

Anticancer Agents Med Chem · 2026 · PMC13223416 · PMID 40442909

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

extremely significantno p-value reported

Triple-negative breast cancer, the most aggressive subtype of breast cancer for which treatment is medically challenging, can originate from another extremely significant mutation in the TP53 gene [ 23 ].

also in 7,787 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.